In the normal stratified squamous epithelium of the esophagus, only the thi
rd to the fifth layers of cells express the cyclin-dependent kinase inhibit
or p21(WAF1/CIP1) (p21). Using immunohistochemical staining, we examined th
e topological distribution of cells expressing p21, p53, Ki67, and cytokera
tin 10 (CK10), a differentiation marker of esophageal squamous cell carcino
ma (SCC), in 25 superficial SCCs and 72 dysplastic lesions of the esophagus
, Image analysis of p21, p53, and Ki67 expression was also performed in 48
dysplastic lesions. In superficial SCCs, although Ki67- and p53-expressing
cells were mainly distributed in the deep layers of tumors despite tumor di
fferentiation, the distribution of p21 correlated with tumor differentiatio
n. In dysplastic lesions, p53- and Ki67-coexpressing cells tended to locate
in the same layers and expand in the lower layers of epithelium with the p
rogression of dysplasia. p21-expressing cells shifted to the upper Layers o
f the epithelium with the progression of dysplasia, However, this change wa
s heterogeneous; in some lesions, p21-expressing cells were confined to the
superficial layers of atypical cells (confined type), whereas in others, p
21-overexpressing cells were scattered among atypical cells (scattered type
). CK10 expression was observed in 25% of dysplastic lesions, and the frequ
ency of CK10 expression was significantly higher in the scattered than in t
he confined type. Our results suggest that esophageal squamous dysplasia re
presents the earliest pathological process in esophageal squamous carcinoge
nesis, Our results also suggest that differentiation of esophageal SCC is d
etermined at the stage of dysplasia, and that p21 plays a critical role in
the differentiation process.